SCHEMBL19645199

SCHEMBL19645199

CCCCCCC(C)(CC)CC(=O)OCC

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
KMT2A Q03164 1/20 0.47
ATM Q13315 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP4F2 P78329 2/20 0.41
CYP4A11 Q02928 2/20 0.41
HTT P42858 1/20 0.40
NAAA Q02083 1/20 0.39
DGKA P23743 1/20 0.39
GAA P10253 2/20 0.39
THRB P10828 1/20 0.38
PKM P14618 1/20 0.38
MGAM O43451 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
CES2 O00748 1/20 0.37
LPAR1 Q92633 1/20 0.37
LPAR3 Q9UBY5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12855109 0.93 GAA (0.40) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL19861159 0.91 MEN1 (0.49) MEN1MAPTKMT2AATML3MBTL1
Ammonia Solution, Strong SCHEMBL27574672 0.91 MEN1 (0.49) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL19645194 0.85 GAA (0.43) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL28617178 0.85 GAA (0.43) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL20198651 0.85 MAPT (0.46) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL20076474 0.85 DGKA (0.50) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL20457453 0.82 FFAR1 (0.48) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL19861329 0.82 FFAR1 (0.48) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL5973054 0.81 GAA (0.50) CYP4F2CYP4A11GAAMGAMSI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9890198-B2 Cyclosporin derivatives and uses thereof S&T GLOBAL INC. (US) 2018-02-13 US disclosed
US-9828378-B2 Kinase inhibitors and methods of use INTELLIKINE LLC (US) 2017-11-28 US disclosed